| Trial name or title | Study to evaluate cardiac assessments following different treatments of smoking cessation medications in subjects with and without psychiatric disorders [CATS] |
| Methods | Double‐blind 4‐arm parallel‐group RCT |
| Participants | 6800 adult smokers, 10+ CPD, motivated to quit; Neuropsychiatric subgroup must have 'proper diagnosis as outlined in protocol' |
| Interventions | Placebo, varenicline, NRT patch, bupropion |
| Outcomes | 1. Time to major adverse cardiac event (MACE) up to 52 wks 2. Abstinence at wk 12, 24 |
| Starting date | May 2012 |
| Contact information | Pfizer,GSK |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.